Stay updated on Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a government funding status notice and NIH Clinical Center operating status guidance; updated version to v3.2.0 (removing v3.1.0).SummaryDifference4%
- Check22 days agoChange DetectedMajor update: new version v3.1.0 with expanded immune system terminology and related entities; old version v3.0.2 removed.SummaryDifference1%
- Check36 days agoChange DetectedVersion updated to v3.0.2 and the Back to Top link was removed; no substantive content changes were observed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated to include new medical terms and therapeutic techniques related to uveal melanoma, while significant content regarding specific locations and various types of tumors has been removed.SummaryDifference5%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab for Liver Metastatic Uveal Melanoma Clinical Trial page.